140 related articles for article (PubMed ID: 35544580)
1. Efficiency of a novel middle ear pressure device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Do TA; Ueda N; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 May; 142(5):388-394. PubMed ID: 35544580
[TBL] [Abstract][Full Text] [Related]
2. 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Ueda N; Do TA; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 Jun; 142(6):491-498. PubMed ID: 35723676
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of middle ear pressure therapy with the EFET01 device in patients with Ménière's disease and delayed endolymphatic hydrops in Japan.
Tram Anh D; Takakura H; Nakazato A; Morita Y; Shojaku H
Acta Otolaryngol; 2023 Oct; 143(10):840-844. PubMed ID: 37995205
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of changes in endolymphatic volume after middle ear pressure therapy for intractable meniere's disease using 3D magnetic resonance imaging.
Kitahara T; Sakagami M; Inui H; Irino H
Acta Otolaryngol; 2023 Apr; 143(4):289-295. PubMed ID: 37067367
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
6. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
7. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
8. Monitoring pressure changes in the inner ear induced by middle ear pressure therapy with an EFET01 device in guinea pigs.
Tram Anh D; Takakura H; Nakazato A; Shojaku H
Acta Otolaryngol; 2023 Aug; 143(8):655-661. PubMed ID: 37537955
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
10. [Delayed endolymphatic hydrops].
Giannoni B; Pagnini P; Vannucchi P
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research.
Iwasaki S; Shojaku H; Murofushi T; Seo T; Kitahara T; Origasa H; Watanabe Y; Suzuki M; Takeda N;
Auris Nasus Larynx; 2021 Feb; 48(1):15-22. PubMed ID: 33131962
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.
Liu B; Leng Y; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
Medicine (Baltimore); 2016 Dec; 95(52):e5767. PubMed ID: 28033296
[TBL] [Abstract][Full Text] [Related]
13. Correlation between magnetic resonance imaging classification of endolymphatic hydrops and clinical manifestations and audiovestibular test results in patients with definite Ménière's disease.
Jasińska A; Lachowska M; Wnuk E; Pierchała K; Rowiński O; Niemczyk K
Auris Nasus Larynx; 2022 Feb; 49(1):34-45. PubMed ID: 33865653
[TBL] [Abstract][Full Text] [Related]
14. Improvement of vertigo symptoms and acoustic power absorbance in cases with endolymphatic hydrops.
Kobayashi M; Yoshida T; Fukunaga Y; Hara D; Sugimoto S; Naganawa S; Sone M
Laryngoscope Investig Otolaryngol; 2024 Feb; 9(1):e1210. PubMed ID: 38362179
[TBL] [Abstract][Full Text] [Related]
15. Delayed endolymphatic hydrops. Special emphasis on nystagmus associated with episodes and contribution of chemical labyrinthectomy.
Reynard P; Karkas A; Gavid M; Lelonge Y; Bertholon P
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):321-326. PubMed ID: 30172621
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
17. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
Kitahara T; Maekawa C; Kizawa K; Horii A; Doi K
Otol Neurotol; 2009 Sep; 30(6):812-9. PubMed ID: 19638944
[TBL] [Abstract][Full Text] [Related]
18. [Middle ear overpressure treatment in severe Menière's disease].
Shojaku H; Watanabe Y; Maruyama M; Motoshima H; Junicho M; Yasumura S
Nihon Jibiinkoka Gakkai Kaiho; 2003 Sep; 106(9):880-3. PubMed ID: 14577325
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of endolymphatic sac drainage with local steroids for intractable Meniere's disease.
Kitahara T; Fukushima M; Uno A; Imai T; Ohta Y; Morihana T; Kamakura T; Horii A; Inohara H
Auris Nasus Larynx; 2013 Oct; 40(5):425-30. PubMed ID: 23273764
[TBL] [Abstract][Full Text] [Related]
20. Changes in endolymphatic hydrops after vestibular neurectomy observed in magnetic resonance imaging - A pilot study.
Jasińska-Nowacka A; Lachowska M; Wnuk E; Niemczyk K
Auris Nasus Larynx; 2022 Aug; 49(4):584-592. PubMed ID: 34949488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
